Cornerstone Advisors (Washington)’s Kyntra Bio KYNB Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-32	Closed	-$36K	–	1035
2019 Q2	$36K	Hold	32	–	–	﹤0.01%	485
2019 Q1	$43K	Buy	32 +28	+700%	+$38K	﹤0.01%	408
2018 Q4	$5K	Hold	4	–	–	﹤0.01%	767
2018 Q3	$6K	Hold	4	–	–	﹤0.01%	741
2018 Q2	$6K	Hold	4	–	–	﹤0.01%	698
2018 Q1	$5K	Hold	4	–	–	﹤0.01%	702
2017 Q4	$5K	Hold	4	–	–	﹤0.01%	696
2017 Q3	$5K	Hold	4	–	–	﹤0.01%	694
2017 Q2	$3K	Hold	4	–	–	﹤0.01%	749
2017 Q1	$2K	Hold	4	–	–	﹤0.01%	795
2016 Q4	$2K	Hold	4	–	–	﹤0.01%	807
2016 Q3	$2K	Sell	4 -4	-50%	-$1.88K	﹤0.01%	782
2016 Q2	$3K	Hold	8	–	–	﹤0.01%	647
2016 Q1	$4K	Hold	8	–	–	﹤0.01%	597
2015 Q4	$6K	Hold	8	–	–	0.01%	520
2015 Q3	$4K	Buy	+8	New	+$4.85K	﹤0.01%	584

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Cornerstone Advisors (Washington)'s KYNB Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Kyntra Bio (KYNB) in Q3 2019, closing a stake of 32 shares — an estimated $36K sold.

Cornerstone Advisors (Washington) first reported a position in KYNB in Q3 2015 and held it in 16 quarters. The position peaked at $43K in Q1 2019. 210 funds tracked by Wall St. Rank hold KYNB as of Q3 2019.

Cornerstone Advisors (Washington) reported no remaining Kyntra Bio position as of Q3 2019 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 32 Kyntra Bio shares in Q3 2019, an estimated $36K.
Cornerstone Advisors (Washington) first reported a position in Kyntra Bio in Q3 2015 and held it in 16 quarters.
Cornerstone Advisors (Washington)'s Kyntra Bio position peaked at $43K in Q1 2019.
210 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.